Company Announcements

Result of AGM

27 September 2022

LONDON, U.K AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI and optical technology for faster and more accurate treatment decisions in wound care, announces that at the AGM held earlier today, all resolutions were duly passed.

Full details of the voting results, below:

 

ResolutionTotal votes for% of votes castTotal votes against% of votes castVotes withheld

(1) To elect Richard Cotton and Martin Mellish (the "Director Nominees") as Class I directors to serve on the board of directors until the 2025 Annual Meeting of Stockholders and until each of their respective successors have been duly elected and qualified

96,621,896

100.0%

--

--

--

(2) To approve the 2022 Long-Term Incentive Plan

65,099,790

67.4%

5,975,420

6.2%

25,546,686

 

 

For further information please contact:

Spectral MD Holdings, Ltd.

investors.spectralmd.com

Wensheng Fan, Chief Executive Officer

via Walbrook PR

Nils Windler, Chief Financial Officer

 

 

 

SP Angel Corporate Finance LLP (NOMAD and Joint Broker)

Tel: +44 (0)20 3470 0470

Stuart Gledhill/Caroline Rowe (Corporate Finance)

Vadim Alexandre/Rob Rees (Sales & Broking)

 

Stifel Nicolaus Europe Limited (Joint Broker)

Charles Hoare / Ben Maddison / Nick Harland /

Will Palmer-Brown

 

 

 

Tel: +44 (0)20 7710 7600

 

 

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Louis Ashe-Jepson

Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7747 515 393

+44 (0)7407 804 654

   

 

About Spectral MD:                                                                                       

We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our DeepView® Wound Imaging System.

www.spectralmd.com

[email protected]